Shing Fung Lee

Cost-effectiveness of Pembrolizumab as a Second-Line Therapy for Hepatocellular Carcinoma

Chi‐Leung Chiang, Sik-Kwan Chan, Shing Fung Lee et al. · JAMA Network Open · 2021 · 54 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

First-Line Atezolizumab Plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma: A Cost-Effectiveness Analysis

Chi‐Leung Chiang, Sik-Kwan Chan, Shing Fung Lee et al. · Cancers · 2021 · 47 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +14

Prognostic value of lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio in follicular lymphoma: a retrospective cohort study

Shing Fung Lee, Miguel Ángel Luque-Fernández · BMJ Open · 2017 · 33 citations · Full text

Medicine, Hematology, Oncology +13

Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidance for the prevention of breast cancer-related arm lymphoedema (BCRAL): international Delphi consensus-based recommendations

Henry C.Y. Wong, Matthew P. Wallen, Adrian Wai Chan et al. · EClinicalMedicine · 2024 · 32 citations · Full text

Medicine, Oncology, Surgery +17

2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients

Samantha K. F. Kennedy, Shannon Goodall, Shing Fung Lee et al. · Supportive Care in Cancer · 2024 · 30 citations

Medicine, Oncology, Pharmacotherapy +16